Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
Chardan Capital

Chardan Capital Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Chardan Capital. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Chardan Capital's equity research team. MarketBeat is not affiliated with or endorsed by Chardan Capital.

Average Return
00.00% 12-Month ROI
Total Ratings
290 Last 12 Months
Buy Ratings
272 Last 12 Months
Sell Ratings
0 Last 12 Months
Companies Covered
94 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$5.59
+2.2%
10/23/2026Reiterated Rating$20.00BuyView details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 10/23/2026
Agenus Inc. stock logo
AGEN
Agenus
$6.33
-2.8%
10/22/2026Reiterated RatingBuyView details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 10/22/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
10/22/2026Reiterated Rating$16.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 10/22/2026
Kodiak AI, Inc. stock logo
KDK
Kodiak AI
$1.02
-1.9%
10/22/2026Lower Price Target$4.50BuyView details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 10/22/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.61
+3.1%
10/22/2026Reiterated RatingBuyView details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 10/22/2026
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
$19.67
+0.1%
10/21/2026 DowngradeStrong-Buy ➝ HoldView details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 10/21/2026
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
$0.94
-3.3%
10/20/2026Initiated CoverageBuyView details for Chardan Capital rating of Tvardi Therapeutics (NASDAQ:TVRD) on 10/20/2026
MannKind Corporation stock logo
MNKD
MannKind
$3.19
-0.3%
10/19/2026Initiated Coverage$10.00BuyView details for Chardan Capital rating of MannKind (NASDAQ:MNKD) on 10/19/2026
VinFast Auto Ltd. stock logo
VFS
VinFast Auto
$3.07
+3.7%
10/16/2026Reiterated Rating$5.50BuyView details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 10/16/2026
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$58.02
-0.6%
10/15/2026Reiterated Rating$115.00BuyView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 10/15/2026
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
$1.59
-2.5%
10/13/2026Set Price Target$1.50NeutralView details for Chardan Capital rating of Inhibikase Therapeutics (NASDAQ:IKT) on 10/13/2026
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$9.60
+1.5%
10/13/2026Initiated CoverageBuyView details for Chardan Capital rating of Gossamer Bio (NASDAQ:GOSS) on 10/13/2026
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
$1.59
-2.5%
10/13/2026Initiated Coverage$1.50HoldView details for Chardan Capital rating of Inhibikase Therapeutics (NASDAQ:IKT) on 10/13/2026
Zapata Quantum stock logo
ZPTA
Zapata Quantum
$0.75
+4.2%
10/13/2026Initiated Coverage$1.00BuyView details for Chardan Capital rating of Zapata Quantum (OTCMKTS:ZPTA) on 10/13/2026
Duos Technologies Group, Inc. stock logo
DUOT
Duos Technologies Group
$5.85
-2.3%
10/9/2026Initiated Coverage$9.50NeutralView details for Chardan Capital rating of Duos Technologies Group (NASDAQ:DUOT) on 10/9/2026
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.29
-0.9%
10/7/2026Reiterated Rating$11.00BuyView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/7/2026
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$10.80
-8.9%
10/6/2026Lower Price Target$26.00 ➝ $25.00BuyView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/6/2026
Agenus Inc. stock logo
AGEN
Agenus
$6.33
-2.8%
10/5/2026Reiterated Rating$40.00BuyView details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 10/5/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
10/2/2026Reiterated Rating$16.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 10/2/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$6.50
-1.7%
10/2/2026Reiterated Rating$23.00BuyView details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 10/2/2026
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
$1.29
-3.0%
10/1/2026Reiterated Rating$3.00BuyView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 10/1/2026
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$15.62
-1.0%
9/30/2026Reiterated Rating$38.00BuyView details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 9/30/2026
QMLS
QumulusAI
$3.20
-6.2%
9/30/2026Reiterated Rating$23.00BuyView details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 9/30/2026
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
$3.30
-2.7%
9/29/2026Lower Price Target$6.50 ➝ $6.00BuyView details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 9/29/2026
Kodiak AI, Inc. stock logo
KDK
Kodiak AI
$1.02
-1.9%
9/25/2026Reiterated Rating$12.00BuyView details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 9/25/2026
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.67
-1.6%
9/25/2026Reiterated Rating$7.00BuyView details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 9/25/2026
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$125.10
-1.0%
9/21/2026Initiated Coverage$240.00BuyView details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 9/21/2026
Agenus Inc. stock logo
AGEN
Agenus
$6.33
-2.8%
9/18/2026Initiated Coverage$40.00BuyView details for Chardan Capital rating of Agenus (NASDAQ:AGEN) on 9/18/2026
Corvex, Inc. stock logo
MOVE
Corvex
$8.46
+4.8%
9/16/2026Set Price Target$18.75BuyView details for Chardan Capital rating of Corvex (NASDAQ:MOVE) on 9/16/2026
HIVE Digital Technologies Ltd. stock logo
HIVE
HIVE Digital Technologies
$1.93
-1.0%
9/16/2026Reiterated Rating$7.50BuyView details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 9/16/2026
Corvex, Inc. stock logo
MOVE
Corvex
$8.46
+4.8%
9/16/2026Initiated Coverage$18.75BuyView details for Chardan Capital rating of Corvex (NASDAQ:MOVE) on 9/16/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$6.50
-1.7%
9/16/2026Reiterated Rating$23.00BuyView details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/16/2026
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.29
-0.9%
9/15/2026Reiterated Rating$11.00BuyView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/15/2026
Adagene Inc. Sponsored ADR stock logo
ADAG
Adagene
$2.41
-1.2%
9/10/2026Initiated Coverage$9.00BuyView details for Chardan Capital rating of Adagene (NASDAQ:ADAG) on 9/10/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
9/9/2026Boost Price Target$13.00 ➝ $16.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
9/9/2026Reiterated Rating$13.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026
Kodiak AI, Inc. stock logo
KDK
Kodiak AI
$1.02
-1.9%
9/9/2026Reiterated Rating$12.00BuyView details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 9/9/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$2.80
-4.1%
9/8/2026Boost Price Target$7.30 ➝ $8.45BuyView details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 9/8/2026
HIND
Vyome
$1.77
-1.7%
9/3/2026Initiated Coverage$3.50BuyView details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026
HIND
Vyome
$1.77
-1.7%
9/3/2026Initiated Coverage$3.50BuyView details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026
This free guide explains options the way they should be taught (Ad)

Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan.tc pixel

Claim your free options guide and start building real trading knowledge
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.29
-0.9%
9/1/2026Initiated Coverage$11.00BuyView details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/1/2026
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$58.02
-0.6%
8/31/2026Reiterated Rating$115.00BuyView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/31/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$8.78
+1.2%
8/28/2026Boost Price Target$9.75 ➝ $17.00BuyView details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/28/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$8.78
+1.2%
8/27/2026Reiterated Rating$9.75BuyView details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/27/2026
Odysight.ai Inc. stock logo
ODYS
Odysight.ai
$2.24
+7.7%
8/26/2026UpgradeStrong-BuyView details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/26/2026
QMLS
QumulusAI
$3.20
-6.2%
8/26/2026Reiterated Rating$24.50BuyView details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/26/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.61
+3.1%
8/26/2026UpgradeStrong-BuyView details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/26/2026
ZOOZ Power Ltd. stock logo
ZOOZ
ZOOZ Power
$6.49
+9.4%
8/26/2026Reiterated Rating$10.00BuyView details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 8/26/2026
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.67
-1.6%
8/25/2026Initiated Coverage$7.00BuyView details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.67
-1.6%
8/25/2026Initiated Coverage$7.00BuyView details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
8/18/2026Downgrade$5.00Buy ➝ NeutralView details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/18/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.61
+3.1%
8/18/2026Initiated CoverageBuyView details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/18/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
8/17/2026Reiterated Rating$65.00 ➝ $5.00Buy ➝ NeutralView details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/17/2026
HIVE Digital Technologies Ltd. stock logo
HIVE
HIVE Digital Technologies
$1.93
-1.0%
8/17/2026Reiterated Rating$7.50BuyView details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 8/17/2026
Odysight.ai Inc. stock logo
ODYS
Odysight.ai
$2.24
+7.7%
8/17/2026Initiated Coverage$7.15BuyView details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/17/2026
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$3.94
-4.8%
8/12/2026Reiterated Rating$14.00BuyView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/12/2026
QMLS
QumulusAI
$3.20
-6.2%
8/12/2026Initiated Coverage$24.50BuyView details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/12/2026
VinFast Auto Ltd. stock logo
VFS
VinFast Auto
$3.07
+3.7%
8/12/2026Reiterated Rating$5.50BuyView details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 8/12/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$2.80
-4.1%
8/11/2026Reiterated Rating$7.30BuyView details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 8/11/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.72
-2.3%
8/11/2026Downgrade$5.00Buy ➝ NeutralView details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026
Cleanspark, Inc. stock logo
CLSK
Cleanspark
$7.88
-3.3%
8/10/2026Reiterated Rating$21.00BuyView details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 8/10/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
8/7/2026Reiterated Rating$65.00BuyView details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/7/2026
Galaxy Digital Inc. stock logo
GLXY
Galaxy Digital
$14.68
-4.0%
8/5/2026Reiterated Rating$35.00BuyView details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 8/5/2026
TeraWulf Inc. stock logo
WULF
TeraWulf
$11.32
8/5/2026Reiterated Rating$32.00BuyView details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 8/5/2026
Cipher Mining Inc. stock logo
CIFR
Cipher Mining
$7.94
-4.6%
8/4/2026Reiterated Rating$32.00BuyView details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 8/4/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$6.50
-1.7%
8/4/2026Reiterated Rating$23.00BuyView details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 8/4/2026
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
$25.04
-2.6%
8/4/2026Reiterated Rating$35.00BuyView details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 8/4/2026
CervoMed Inc. stock logo
CRVO
CervoMed
$2.31
+3.1%
8/3/2026UpgradeStrong-BuyView details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 8/3/2026
Immuneering Corporation stock logo
IMRX
Immuneering
$3.73
-2.1%
8/3/2026UpgradeStrong-BuyView details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/3/2026
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$311.50
-2.7%
8/3/2026 UpgradeStrong-BuyView details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/3/2026
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$224.03
-1.4%
7/31/2026Reiterated Rating$425.00BuyView details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.72
-2.3%
7/31/2026Reiterated Rating$27.00BuyView details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/31/2026
Cleanspark, Inc. stock logo
CLSK
Cleanspark
$7.88
-3.3%
7/28/2026Boost Price Target$19.00 ➝ $21.00BuyView details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/28/2026
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$10.80
-8.9%
7/28/2026UpgradeStrong-BuyView details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/28/2026
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
$2.80
-3.1%
7/28/2026UpgradeStrong-BuyView details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/28/2026
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$125.10
-1.0%
7/28/2026UpgradeStrong-BuyView details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 7/28/2026
Promis Neurosciences stock logo
PMN
Promis Neurosciences
$8.34
-7.1%
7/27/2026Set Price Target$20.00BuyView details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026
HIVE Digital Technologies Ltd. stock logo
HIVE
HIVE Digital Technologies
$1.93
-1.0%
7/27/2026Initiated Coverage$7.50BuyView details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026
Cipher Mining Inc. stock logo
CIFR
Cipher Mining
$7.94
-4.6%
7/27/2026Initiated Coverage$32.00BuyView details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026
TeraWulf Inc. stock logo
WULF
TeraWulf
$11.32
7/27/2026Initiated Coverage$32.00BuyView details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026
Cipher Mining Inc. stock logo
CIFR
Cipher Mining
$7.94
-4.6%
7/27/2026Initiated Coverage$32.00BuyView details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026
HIVE Digital Technologies Ltd. stock logo
HIVE
HIVE Digital Technologies
$1.93
-1.0%
7/27/2026Initiated Coverage$7.50BuyView details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026
Promis Neurosciences stock logo
PMN
Promis Neurosciences
$8.34
-7.1%
7/27/2026Initiated Coverage$20.00BuyView details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026
TeraWulf Inc. stock logo
WULF
TeraWulf
$11.32
7/27/2026Initiated Coverage$32.00BuyView details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$58.02
-0.6%
7/22/2026Boost Price Target$90.00 ➝ $115.00BuyView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/22/2026
Cleanspark, Inc. stock logo
CLSK
Cleanspark
$7.88
-3.3%
7/15/2026Reiterated Rating$19.00BuyView details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/15/2026
Cleanspark, Inc. stock logo
CLSK
Cleanspark
$7.88
-3.3%
7/8/2026Reiterated Rating$19.00BuyView details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2026
Metagenomi, Inc. stock logo
MGX
Metagenomi
$0.81
-1.3%
7/7/2026Initiated Coverage$7.00 ➝ $5.00BuyView details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 7/7/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
7/6/2026Reiterated Rating$13.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 7/6/2026
iBio, Inc. stock logo
IBIO
iBio
$0.72
-8.4%
7/2/2026Reiterated Rating$5.00BuyView details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 7/2/2026
Financial legend: “This is bad, really bad...” (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.72
-2.3%
7/2/2026Reiterated Rating$27.00BuyView details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/2/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
7/1/2026Boost Price Target$29.00 ➝ $65.00BuyView details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 7/1/2026
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$58.02
-0.6%
6/30/2026Reiterated Rating$90.00BuyView details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/30/2026
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
$1.29
-3.0%
6/26/2026Lower Price Target$4.00 ➝ $3.00BuyView details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 6/26/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$6.50
-1.7%
6/25/2026Boost Price Target$21.00 ➝ $23.00BuyView details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 6/25/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.72
-2.3%
6/22/2026Initiated Coverage$27.00BuyView details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 6/22/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
6/18/2026Boost Price Target$11.00 ➝ $13.00BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/18/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
6/17/2026UpgradeStrong-BuyView details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/17/2026
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
$2.84
-6.6%
6/17/2026Boost Price Target$14.00 ➝ $16.00BuyView details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 6/17/2026
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
$3.94
-4.8%
6/12/2026Reiterated Rating$14.00BuyView details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/12/2026

MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms in the last 90 days. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Chardan Capital Stock Coverage by Sector

Chardan Capital concentrates its research most heavily in Healthcare (77.7%), Technology (14.9%) and Industrials (3.2%). The chart below shows how Chardan Capital's 94 rated companies are distributed across all 5 sectors it covers.

Chardan Capital - Frequently Asked Questions

Chardan Capital's analysts currently have buy-equivalent ratings on 88 companies. Recent upgrades to buy include Odysight.ai, Rani Therapeutics, Krystal Biotech, Immuneering and CervoMed.

Chardan Capital's highest-rated analysts by MarketBeat's accuracy score include Daniil Gataulin, Geulah Livshits and Rudy Li. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 9 analysts at Chardan Capital.

Chardan Capital has the deepest coverage in Healthcare (77.7% of rated companies), Technology (14.9% of rated companies), Industrials (3.2% of rated companies), Finance (2.1% of rated companies) and Consumer Discretionary (1.1% of rated companies).

Chardan Capital issued 290 ratings over the last 12 months across 94 companies — an average of roughly 24 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Chardan Capital analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Chardan Capital uses Buy, Neutral, and Sell as their equivalents.